Atropos Health Expands Federated Evidence Network with Multimodal Data Partners
Event summary
- Atropos Health expanded its federated Atropos Evidence™ Network with new data partnerships, including OneMedNet Corporation.
- The network now covers over 330 million U.S. patients, 150 million+ EHR records, and includes multimodal data like imaging and omics.
- Partnerships enable faster and more cost-effective data analytics, with queries running up to 50 times faster and 30 times more cost-effectively.
- The network supports applications in RWE, HEOR, commercial analytics, and AI model training.
The big picture
Atropos Health's expansion of its federated evidence network aligns with the growing demand for high-quality, real-world data to support AI-driven healthcare innovations. By integrating multimodal data and leveraging advanced de-identification technology, the company is positioning itself as a key player in the shift toward evidence-based clinical decision-making. The partnerships with Norstella, Arcadia, and OneMedNet Corporation underscore the strategic importance of scalable, privacy-first data ecosystems in the life sciences and healthcare sectors.
What we're watching
- Data Integration
- How the integration of multimodal data will enhance the precision and reliability of AI models and clinical decision support.
- Market Dynamics
- Whether the expanded network will accelerate adoption by life sciences and health systems, driving competitive differentiation.
- Regulatory Compliance
- The pace at which regulatory-grade RWE applications will be developed and validated using the network's de-identified data.